NCCN adds Blue Earth's Posluma to its oncology guidelines
The NCCN has added Blue Earth Diagnostics' Posluma PET radiotracer to its guidelines for imaging prostate cancer.
-- The National Comprehensive Cancer Network (NCCN) has added Blue Earth Diagnostics ' Posluma (Flotufolastat F-18) PET radiotracer to its oncology guidelines f...
Read More
Other Stories in Health
- Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms
- Food additive emulsifiers linked to increased risk of type 2 diabetes
- Yoga practices to follow to manage autoimmune disorders
- USAMRAA grant supports COPD biosensor project at The Lundquist Institute
- Breast cancer survivors at higher risk of developing second cancers
- World Malaria Day 2024: Health tips for quick recovery
- IBS Diet: 6 food items should be avoided
- Opioids more potent than fentanyl have been detected in Australia. So what are nitazenes?
- Where would you attend? Yale v Vanderbilt
.png)
